Skip to main content
Clinical Trials/NCT05333770
NCT05333770
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation as a Means to Promote CST Axon Regeneration in Persons With Spinal Cord Injury

Kessler Foundation1 site in 1 country20 target enrollmentStarted: August 20, 2022Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Kessler Foundation
Enrollment
20
Locations
1
Primary Endpoint
GRASSP

Overview

Brief Summary

This is a research study to evaluate the safety, efficacy and feasibility of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in patients with subacute spinal cord injury.

Detailed Description

This research study is investigating whether repetitive high-frequency transcranial magnetic stimulation (HF-rTMS) in patients with subacute spinal cord injury is safe, efficacious, and feasible. The study will take approximately 7-8 months to complete, during which 15 training sessions with HF-rTMS will be completed. Followed by 30 minutes each session of arm and hand training without HF-rTMS. The participants will complete testing after the 15 training sessions as well as 6 months following completion.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Be less than 8 weeks post injury
  • Must have an incomplete spinal cord injury at a neurological level of injury between the C2-C6 level and an impairment grade A, B, C, or D, according to the American Spinal Injury association (ASIA) Impairment Scale
  • If an outpatient, will be at least 6 months post injury

Exclusion Criteria

  • Have a pacemaker
  • Have metal in the skull
  • Have a history of seizures, or a brain injury
  • Being pregnant
  • Have skin issues or open wounds
  • Have severe contractures and/or spasms in my elbow/wrists as determined by study staff examination at screening
  • Study staff will review medications to determine if taking any drugs that would increase risk of having a seizure while undergoing TMS. If taking such medications, will not be enrolled

Outcomes

Primary Outcomes

GRASSP

Time Frame: 6 months

The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) is an extensive and validated impairment and functional measure which is able to detect subtle neurologic changes in individuals with spinal cord injury. Specifically, it evaluates the domains of sensation, strength, quality of different grip patterns and the ability to complete a variety of functional tasks.

Neuro Recovery Scale (NRS).

Time Frame: 6 months

Measure of the degree a person who has sustained a spinal cord injury (SCI) has recovered the ability to perform functional tasks relative to how the individual performed these tasks prior to injury. The NRS consists of a numeric version of the visual analog scale. The most common form of the NRS is a horizontal line with an eleven point numeric range. It is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible. This type of scale can be administered verbally.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kessler Foundation
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials